rs144303334

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_014363.6(SACS):​c.973G>A​(p.Gly325Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000197 in 1,614,100 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G325E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 1 hom. )

Consequence

SACS
NM_014363.6 missense

Scores

6
7
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 6.11

Publications

7 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, PanelApp Australia, G2P, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.026564896).
BP6
Variant 13-23355639-C-T is Benign according to our data. Variant chr13-23355639-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 448230.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.973G>Ap.Gly325Arg
missense
Exon 8 of 10NP_055178.3
SACS
NM_001437336.1
c.973G>Ap.Gly325Arg
missense
Exon 8 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.532G>Ap.Gly178Arg
missense
Exon 6 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.973G>Ap.Gly325Arg
missense
Exon 8 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.973G>Ap.Gly325Arg
missense
Exon 8 of 11ENSP00000406565.2H0Y6M8
SACS
ENST00000682944.1
c.973G>Ap.Gly325Arg
missense
Exon 8 of 11ENSP00000507173.1A0A804HIQ1

Frequencies

GnomAD3 genomes
AF:
0.000224
AC:
34
AN:
152092
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000390
AC:
98
AN:
251422
AF XY:
0.000390
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00744
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000194
AC:
284
AN:
1461890
Hom.:
1
Cov.:
34
AF XY:
0.000182
AC XY:
132
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00704
AC:
184
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000540
AC:
60
AN:
1112010
Other (OTH)
AF:
0.000613
AC:
37
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000223
AC:
34
AN:
152210
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41508
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00778
AC:
27
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68018
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000341
Hom.:
0
Bravo
AF:
0.000227
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000280
AC:
34
EpiCase
AF:
0.000109
EpiControl
AF:
0.000296

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Charlevoix-Saguenay spastic ataxia (2)
-
1
1
not provided (2)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.33
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.59
D
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.80
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.027
T
MetaSVM
Benign
-0.30
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
6.1
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-2.6
D
REVEL
Pathogenic
0.65
Sift
Benign
0.055
T
Sift4G
Uncertain
0.0050
D
Polyphen
0.98
D
Vest4
0.60
MutPred
0.46
Loss of sheet (P = 0.0126)
MVP
0.86
ClinPred
0.22
T
GERP RS
5.6
Varity_R
0.33
gMVP
0.79
Mutation Taster
=16/84
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144303334; hg19: chr13-23929778; COSMIC: COSV101207898; API